Status:
COMPLETED
Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors
Lead Sponsor:
Center for International Blood and Marrow Transplant Research
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
National Marrow Donor Program
Conditions:
Adult Hematopoietic Cell Transplant (HCT) Survivors 1-2 Yrs Post Most Recent HCT
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This randomized study will compare a personalized Survivorship Care Plan (SCP) template with usual care (no SCP). The investigators hypothesize that the personalized SCP that incorporates patient spec...
Detailed Description
This randomized study will compare a personalized Survivorship Care Plan (SCP) template with usual care (no SCP). The investigators hypothesize that the personalized SCP that incorporates patient spec...
Eligibility Criteria
Inclusion
- Adult (≥ 18 years at time of allogeneic HCT recipient at participating transplant centers)
- Survival 1-2 years after most recent HCT with no evidence of relapse, disease progression, or secondary cancer on last follow-up
- All diagnoses will be eligible
- All transplant types will be eligible (autologous or allogeneic related or unrelated)
- All graft sources will be eligible (bone marrow, peripheral blood or umbilical cord blood)
- All conditioning regimens will be eligible (in case of allogeneic HCT, patient could have received myeloablative or non-myeloablative/reduced-intensity conditioning)
- Patient may have received more than one HCT
- Patient must be proficient in English (written and spoken) to complete study assessments
- Patient must have a valid mailing address within the United States to receive study materials
- Signed informed consent form from patient
Exclusion
- \- Patients who have received their transplant at a different transplant center will not be eligible for the study
Key Trial Info
Start Date :
April 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2017
Estimated Enrollment :
495 Patients enrolled
Trial Details
Trial ID
NCT02200133
Start Date
April 1 2015
End Date
April 1 2017
Last Update
September 7 2017
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Scottsdale, Arizona, United States, 85259-5499
2
University of Florida, Shands Hospital
Gainesville, Florida, United States, 32608
3
Loyola Medical Center
Maywood, Illinois, United States, 60153
4
University of Kansas Cancer Center
Westwood, Kansas, United States, 66205